Our findings indicated that, in the GSE68465 cohort, the COL7A1-H group had a lower tumor purity compared to the COL7A1-L group (Figure 7A), while the immune, stromal, and ESTIMATE scores were the opposite with significant statistical differences (Figures 7B–D). The gene discussed is COL7A1; the disease is neoplasm.